- Home
- RDY vs JANX Comparison
RDY vs JANX Comparison
Compare RDY & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDY
- JANX
- Stock Information
- Founded
- RDY 1984
- JANX 2017
- Country
- RDY India
- JANX United States
- Employees
- RDY N/A
- JANX N/A
- Industry
- RDY Biotechnology: Pharmaceutical Preparations
- JANX Biotechnology: Pharmaceutical Preparations
- Sector
- RDY Health Care
- JANX Health Care
- Exchange
- RDY Nasdaq
- JANX Nasdaq
- Market Cap
- RDY 2.1B
- JANX 2.2B
- IPO Year
- RDY N/A
- JANX 2021
- Fundamental
- Price
- RDY $13.17
- JANX $26.81
- Analyst Decision
- RDY Buy
- JANX Strong Buy
- Analyst Count
- RDY 1
- JANX 8
- Target Price
- RDY $17.00
- JANX $91.25
- AVG Volume (30 Days)
- RDY 1.9M
- JANX 784.7K
- Earning Date
- RDY 05-06-2025
- JANX 05-06-2025
- Dividend Yield
- RDY 3.63%
- JANX N/A
- EPS Growth
- RDY 2.68
- JANX N/A
- EPS
- RDY 0.75
- JANX N/A
- Revenue
- RDY $3,637,607,642.00
- JANX $10,588,000.00
- Revenue This Year
- RDY $17.23
- JANX N/A
- Revenue Next Year
- RDY $9.19
- JANX $289.47
- P/E Ratio
- RDY $17.92
- JANX N/A
- Revenue Growth
- RDY 14.74
- JANX 30.99
- 52 Week Low
- RDY $12.50
- JANX $26.39
- 52 Week High
- RDY $16.89
- JANX $71.71
- Technical
- Relative Strength Index (RSI)
- RDY 45.70
- JANX 29.87
- Support Level
- RDY $13.10
- JANX $29.77
- Resistance Level
- RDY $13.85
- JANX $32.00
- Average True Range (ATR)
- RDY 0.13
- JANX 1.44
- MACD
- RDY 0.03
- JANX -0.00
- Stochastic Oscillator
- RDY 48.88
- JANX 7.01
About RDY Dr. Reddy's Laboratories Ltd
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly half of its generics sales, and it services India (about 20% of its generics sales), Russia (10%), and certain European and Latin American countries. Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing next-generation therapeutics based on proprietary tumor activated T Cell Engager platform technology to treat patients suffering from cancer.